“Ross and Dwyer are at the centre of the country's first clinical trial of psychedelic drugs for treating severe depression in the terminally ill. Within a month, they will begin recruiting 40 depressed and incurable patients in an attempt to relieve their distress with a novel treatment: between one and two 25-milligram doses of synthetic psilocybin, the psychedelic ingredient found in "magic mushrooms", accompanied by intensive psychotherapy sessions…”
Read More“A new systematic review states that serotonergic hallucinogens help users recognize emotions in facial expressions. Sufferers of anxiety and depression often only read negative emotions in other people's faces, adding to their malaise. While more research is needed, psychedelics could prove to be a powerful agent in battling mental health disorders…”
Read More“New research provides evidence that the ritualistic use of the psychedelic drug ayahuasca is not a significant public health concern — and could in fact have potential benefits. The study has been published in the Journal of Psychoactive Drugs…”
Read MoreSo, what about using ancient plant medicines to treat addiction? It may seem completely contradictory to treat someone who has a substance use disorder with a psychedelic drug that may induce hallucinations, but there's emerging evidence to support this approach…
Read More
